Literature DB >> 8174100

High expression rate of Tn antigen in metastatic lesions of uterine cervical cancers.

S Hamada1, H Furumoto, M Kamada, T Hirao, T Aono.   

Abstract

The significance of altered expression of MN blood group antigens was examined by studies on the expressions of Thomsen-Friedenreich antigen (T antigen) and Tn antigen in primary and metastatic lesions of 29 human uterine cervical cancers. These antigens were measured by the avidin-biotin-peroxidase (ABC) method with peanut agglutinin (PNA) lectin for T antigen and Vicia villosa agglutinin (VVA) lectin for Tn antigen. Proportion of cancer cells expressing Tn antigen was higher in the metastatic lesions than in the primary tumors in 10 of the 29 cases, less in the metastasis than in the primary tumor in one case, and similar in the primary and metastatic lesions in the other 18 cases. Reaction for Tn antigen was positive in 24 (82.8%) of the 29 metastases, and in 17 (58.5%) of the 29 primary lesions. Thus, the rate of Tn antigen expression was significantly higher in the metastases than in the primary lesions (P < 0.05). On the other hand, there was no significant difference between the immunoreactivities of T antigen in metastases and primary tumors. These findings support our previous suggestion that expression of Tn antigen is closely related to the metastasis to regional lymph nodes and may reflect an important role of this carbohydrate in the process of metastasis of cervical cancer.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8174100     DOI: 10.1016/0304-3835(93)90239-6

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  8 in total

Review 1.  Simple sugars to complex disease--mucin-type O-glycans in cancer.

Authors:  Matthew R Kudelka; Tongzhong Ju; Jamie Heimburg-Molinaro; Richard D Cummings
Journal:  Adv Cancer Res       Date:  2015-02-07       Impact factor: 6.242

2.  Correlation of Tn antigen expression with mucins in Chinese patients with colorectal cancer.

Authors:  Yuliang Jiang; Zhe Liu; Yizhang Hu; Tianbo Gao; Tao Wen; Guangyu An
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

Review 3.  Glycosylation in cancer: its application as a biomarker and recent advances of analytical techniques.

Authors:  Yoshimi Haga; Koji Ueda
Journal:  Glycoconj J       Date:  2022-02-14       Impact factor: 2.916

4.  Differential expression of the cancer associated antigens T (Thomsen-Friedenreich) and Tn to the skin in primary and metastatic carcinomas.

Authors:  J Kanitakis; I al-Rifai; M Faure; A Claudy
Journal:  J Clin Pathol       Date:  1998-08       Impact factor: 3.411

5.  GalNAcalpha1-3Gal, a new prognostic marker for cervical cancer.

Authors:  Qian Li; Miriam R Anver; Zhitao Li; Donna O Butcher; Jeffrey C Gildersleeve
Journal:  Int J Cancer       Date:  2010-01-15       Impact factor: 7.396

6.  Use of sialylated or sulfated derivatives and acrylamide copolymers of Gal beta 1,3GalNAc alpha- and GalNAc alpha- to determine the specificities of blood group T- and Tn-specific lectins and the copolymers to measure anti-T and anti-Tn antibody levels in cancer patients.

Authors:  Y Chen; R K Jain; E V Chandrasekaran; K L Matta
Journal:  Glycoconj J       Date:  1995-02       Impact factor: 2.916

7.  Binding of galectin-1 to breast cancer cells MCF7 induces apoptosis and inhibition of proliferation in vitro in a 2D- and 3D- cell culture model.

Authors:  Pamina Geiger; Barbara Mayer; Irmi Wiest; Sandra Schulze; Udo Jeschke; Tobias Weissenbacher
Journal:  BMC Cancer       Date:  2016-11-08       Impact factor: 4.430

8.  T-Synthase Deficiency Enhances Oncogenic Features in Human Colorectal Cancer Cells via Activation of Epithelial-Mesenchymal Transition.

Authors:  Xichen Dong; Yuliang Jiang; Jian Liu; Zhe Liu; Tianbo Gao; Guangyu An; Tao Wen
Journal:  Biomed Res Int       Date:  2018-06-21       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.